Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Metastasis02:30

Metastasis

6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

3.0K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutations.

Nature geneticsΒ·2026
Same author

Preclinical response of uveal melanomas to the velcrin compound, BAY 2666605.

Molecular cancer therapeuticsΒ·2026
Same author

Aneuploidy sensitizes cells to SREBP-pathway inhibition in squamous cell carcinoma.

bioRxiv : the preprint server for biologyΒ·2026
Same author

A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception.

Cancer discoveryΒ·2026
Same author

Publisher Correction: Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs.

Nature chemical biologyΒ·2025
Same author

Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs.

Nature chemical biologyΒ·2025
Same journal

ZNRF3 and RNF43 are active monomeric E3 ubiquitin ligases that self-associate.

Science signalingΒ·2026
Same journal

Allosteric ligands with distinct properties uncover tissue-specific physiological regulation mediated by free fatty acid receptor 2.

Science signalingΒ·2026
Same journal

Diacylglycerol kinase ΞΆ in B lymphocytes supports CD40-mediated immune synapse formation, mTORC1 signaling, and plasma cell fate.

Science signalingΒ·2026
Same journal

The APC/C adaptor Cdh1 stabilizes STING to potentiate innate immune activation in renal cell carcinoma.

Science signalingΒ·2026
Same journal

Fattening mother's milk with oxytocin.

Science signalingΒ·2026
Same journal

Virion display reveals MD-1 as an endogenous agonist for the orphan receptor GPRC5B.

Science signalingΒ·2026
See all related articles

Related Experiment Video

Updated: Dec 12, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.8K

Bacterial invaders drive CRC progression.

Matthew Meyerson1,2,3

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Science Signaling
|August 14, 2020
PubMed
Summary
This summary is machine-generated.

The oral bacterium Fusobacterium nucleatum, commonly found in colorectal cancer (CRC), promotes cytokine secretion. This may enhance tumor growth and metastasis in CRC patients.

More Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.6K
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.3K

Related Experiment Videos

Last Updated: Dec 12, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.8K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.6K
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.3K

Area of Science:

  • Microbiology
  • Oncology
  • Immunology

Background:

  • Fusobacterium nucleatum is an oral bacterium frequently detected in colorectal cancer (CRC) tissues.
  • The specific mechanisms by which F. nucleatum influences CRC progression remain incompletely understood.

Purpose of the Study:

  • To investigate the role of F. nucleatum residing within CRC cells in modulating the tumor microenvironment.
  • To determine if F. nucleatum influences the secretion of cytokines that could impact tumor growth and metastasis.

Main Methods:

  • Co-culture of CRC cells with F. nucleatum.
  • Analysis of cytokine secretion profiles using techniques such as ELISA or multiplex assays.
  • Assessment of the impact of F. nucleatum-induced cytokine secretion on CRC cell behavior.

Main Results:

  • CRC cell-resident F. nucleatum significantly promotes the secretion of specific cytokines.
  • These induced cytokines may create a pro-tumorigenic microenvironment.
  • The findings suggest a direct role for F. nucleatum in potentiating tumor growth and metastatic progression.

Conclusions:

  • Fusobacterium nucleatum within CRC cells actively contributes to the tumor microenvironment by inducing cytokine secretion.
  • This cytokine induction by F. nucleatum may drive tumor growth and facilitate metastatic spread in colorectal cancer patients.
  • Targeting F. nucleatum or its associated signaling pathways could represent a therapeutic strategy for CRC.